Gland Pharma Q4 profit surges 2x on strong US launches, CDMO growth; declares ₹20 dividend
The board recommended a final dividend of ₹20 per equity share for FY26, subject to shareholder approval. Shares of Gland Pharma Ltd ended at ₹1,861.00,…
Latest News
ITC Hotels Q4 Results: Profit rises 23%; company acquires Kerala luxury resort for ₹205 crore
ITC Hotels Q4FY26 profit rose 23 percent to 316 crore on 18.2 percent revenue growth, acquires The Zuri Kumarakom Resort and Spa in Kerala for…
Jain Irrigation Q4 Result: Shares fall 5% as company slips into loss, EBITDA up 7%
Jain Irrigation shares fell over 5 percent as Q4FY26 and FY26 swung to net losses despite higher revenue and EBITDA, with exceptional items and global…
World Gold Council sees clearer path for India’s gold market after PM’s appeal
Sachin Jain, Regional CEO – India at the World Gold Council believes the long-term fix lies in three things — building a domestic gold mining…
Thangamayil Jewellery shares volatile after strong Q4 results, rise up to 7%
Thangamayil Jewellery’s revenue came in at ₹2,839.2 crore compared to ₹1,380.5 crore in the fourth quarter last fiscal.
Walmart-owned Flipkart to defer IPO; prioritise profitability this financial year
Walmart has asked Flipkart to delay its IPO and pre IPO funding, focus on achieving EBITDA breakeven by FY 2027, and prioritize profitable units amid…
SJVN Q4 Result: Buxar revenue recognition aids 3x topline growth amidst net loss
SJVN’s finance costs more than tripled from last year to ₹522.1 crore from ₹159.4 crore. Depreciation, Amortisation and Impairment expenses also jumped to ₹494 crore…
Nazara Tech shares surge 18% after block deal; sources say Nikhil Kamath among likely buyers
Zerodha’s Nikhil Kamath and existing shareholder Axana Estates are likely the buyers in the block deals, people in know told CNBC-TV18. The founder Nitish Mittersain…
Oil price pressure priced in, India offers selective opportunities: Raymond James strategist
India’s first fuel price hike in four years partially addresses ₹1 lakh crore in oil marketing company losses, but Matt Orton of Raymond James Investment…
Hester Biosciences Q4 Results: Stock jumps 14% after profit growth, strong operating performance
Hester Biosciences’ board has recommended a dividend of ₹11 per equity share for FY26, subject to shareholder approval at the upcoming annual general meeting.